Read the Latest
A decision from February 13, 2026, by the United States Court of Appeals for the Fifth Circuit provides a rare opportunity for celebration.
David B. Brushwood, BSPharm, JD
Pharmacists in Delaware can now be reimbursed for a broad scope of patient care services within the state’s Medicaid program as well as with all commercial insurers in the state.
Loren Bonner
The question now is not if cannabis will become a Schedule III drug but when. At the end of 2025, President Donald Trump signed an executive order to accelerate the process of rescheduling cannabis under the Controlled Substances Act.
Change is challenging for many individuals—including health care professionals.
Lauren Howell, PharmD, MHA
Whether it’s initiating prior authorizations or delegating tasks to pharmacy personnel, the ways in which pharmacists lead are endless. No matter the role they are in or the title they hold, pharmacists are leaders.
EO CEO Blog